EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review)

Bohao Zheng, Ying Han, Haiying Zhang

International Journal of Molecular Medicine · 01.12.2025 · 57 (2) · 1-17

DOI: 10.3892/ijmm.2025.5704 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 01.12.2025. Verfasst von Bohao Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110000, P.R. China. Hauptthemen laut MEDLINE: Glioblastoma, Matrix Metalloproteinases, Brain Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most aggressive primary malignant brain tumor type in adults, and is characterized by high invasiveness, therapeutic resistance and recurrence. Current treatments, primarily surgery combined with radiotherapy and chemotherapy, offer limited efficacy, thus necessitating more effective interventions. Matrix metalloproteinases (MMPs) crucially contribute to GBM progression through extracellular matrix degradation, epithelial‑mesenchymal transition and angiogenesis. MMP expression is intricately regulated by signaling pathways, non‑coding RNAs and the tumor microenvironment. Recently, strategies targeting MMPs have gained attention, including natural active substances and small‑molecule compounds with promising therapeutic potential. Nano‑delivery systems have notably improved drug delivery efficiency to the brain by overcoming the blood‑brain barrier, and combination therapies have demonstrated enhanced efficacy. However, chemotherapy resistance and functional heterogeneity remain critical challenges. The present review summarizes recent advances in understanding MMP regulatory mechanisms in GBM, highlighting the roles of signaling pathways and non‑coding RNAs. Additionally, the therapeutic potential of natural products, small‑molecule inhibitors, smart nanocarriers and combination treatments are discussed. Future research should focus on identifying novel inhibitors, and leveraging interdisciplinary approaches to facilitate precision‑targeted drug development, thereby addressing current treatment bottlenecks in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMatrix MetalloproteinasesBrain NeoplasmsAntineoplastic AgentsHumansAnimalsNeoplasm InvasivenessSignal TransductionTumor MicroenvironmentDrug Delivery SystemsMatrix Metalloproteinase Inhibitors

Stichwörter der Autor:innen

drug interventionglioblastomamatrix metalloproteinasestumor cell invasion

Substanzen

Matrix MetalloproteinasesAntineoplastic AgentsMatrix Metalloproteinase Inhibitors

Autor:innen und Institutionen

  • The First Clinical College of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110000, P.R. China.

Zitieren

APA

Zheng, B., Han, Y., & Zhang, H. (2025). Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review). International Journal of Molecular Medicine, 57(2), 1-17. https://doi.org/10.3892/ijmm.2025.5704

Vancouver

Zheng B, Han Y, Zhang H. Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review). International Journal of Molecular Medicine. 2025;57(2):1-17. doi:10.3892/ijmm.2025.5704

BibTeX
@article{Zheng2025,
  author = {Zheng, Bohao and Han, Ying and Zhang, Haiying},
  title = {Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2025},
  volume = {57},
  number = {2},
  pages = {1--17},
  doi = {10.3892/ijmm.2025.5704}
}
Kostenlos starten →